JP2014509522A5 - - Google Patents

Download PDF

Info

Publication number
JP2014509522A5
JP2014509522A5 JP2014501809A JP2014501809A JP2014509522A5 JP 2014509522 A5 JP2014509522 A5 JP 2014509522A5 JP 2014501809 A JP2014501809 A JP 2014501809A JP 2014501809 A JP2014501809 A JP 2014501809A JP 2014509522 A5 JP2014509522 A5 JP 2014509522A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
seq
acid sequence
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014501809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014509522A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2012/000131 external-priority patent/WO2012131670A2/en
Publication of JP2014509522A publication Critical patent/JP2014509522A/ja
Publication of JP2014509522A5 publication Critical patent/JP2014509522A5/ja
Pending legal-status Critical Current

Links

JP2014501809A 2011-03-28 2012-03-26 肺癌を分類するための方法 Pending JP2014509522A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161468077P 2011-03-28 2011-03-28
US61/468,077 2011-03-28
PCT/IL2012/000131 WO2012131670A2 (en) 2011-03-28 2012-03-26 Methods for lung cancer clasification

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016213582A Division JP6140352B2 (ja) 2011-03-28 2016-10-31 肺癌を分類するための方法

Publications (2)

Publication Number Publication Date
JP2014509522A JP2014509522A (ja) 2014-04-21
JP2014509522A5 true JP2014509522A5 (enExample) 2015-04-09

Family

ID=46932010

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014501809A Pending JP2014509522A (ja) 2011-03-28 2012-03-26 肺癌を分類するための方法
JP2016213582A Expired - Fee Related JP6140352B2 (ja) 2011-03-28 2016-10-31 肺癌を分類するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016213582A Expired - Fee Related JP6140352B2 (ja) 2011-03-28 2016-10-31 肺癌を分類するための方法

Country Status (5)

Country Link
US (1) US9914972B2 (enExample)
EP (1) EP2691545B1 (enExample)
JP (2) JP2014509522A (enExample)
CN (1) CN103764844A (enExample)
WO (1) WO2012131670A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3149209B1 (en) * 2014-05-30 2021-02-17 Genecentric Therapeutics, Inc. Methods for typing of lung cancer
RU2712511C2 (ru) * 2014-09-08 2020-01-29 Мираген Терапеутикс, Инк. Миметики mir-29 и пути их применения
CN106126827B (zh) * 2016-06-28 2019-04-12 华中科技大学 一种数控装备健康指数的监测方法
CN109224076B (zh) * 2018-11-14 2021-11-19 苏州吉玛基因股份有限公司 与肺癌诊疗相关的基因miR-140-3P及其mimics和应用
CN113228190B (zh) * 2018-12-23 2024-06-11 豪夫迈·罗氏有限公司 分类和/或鉴定癌症亚型的系统和方法
CN110488019A (zh) * 2019-07-31 2019-11-22 四川大学华西医院 Reps1自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
PL241607B1 (pl) * 2019-11-29 2022-11-07 Univ Medyczny W Bialymstoku Panel biomarkerów miRNA do diagnozowania różnicowego podtypów histopatologicznych niedrobnokomórkowego raka płuca
CN113538201B (zh) * 2021-07-26 2022-06-21 景德镇陶瓷大学 基于换底机制的陶瓷水印模型训练方法、装置和嵌密方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541308A (en) * 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
WO2002000001A2 (en) 2000-06-30 2002-01-03 Ingenium Pharmaceuticals Ag HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
WO2008104985A2 (en) * 2007-03-01 2008-09-04 Rosetta Genomics Ltd. Methods for distingushing between lung squamous carcinoma and other non smallcell lung cancers
US7514219B2 (en) 2005-11-16 2009-04-07 The Wistar Institute Method for distinguishing between head and neck squamous cell carcinoma and lung squamous cell carcinoma
WO2007081720A2 (en) 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
US7955848B2 (en) * 2006-04-03 2011-06-07 Trustees Of Dartmouth College MicroRNA biomarkers for human breast and lung cancer
WO2008104984A2 (en) 2007-03-01 2008-09-04 Rosetta Genomics Ltd. Diagnosis and prognosis of various types of cancers
WO2010073248A2 (en) * 2008-12-24 2010-07-01 Rosetta Genomics Ltd. Gene expression signature for classification of tissue of origin of tumor samples
US8802599B2 (en) * 2007-03-27 2014-08-12 Rosetta Genomics, Ltd. Gene expression signature for classification of tissue of origin of tumor samples
CA2678919A1 (en) * 2007-03-27 2008-10-02 Ranit Aharonov Gene expression signature for classification of cancers
CA2700215A1 (en) 2007-10-31 2009-05-07 Rosetta Genomics Ltd. Diagnosis and prognosis of specific cancers
US9249455B2 (en) * 2008-04-18 2016-02-02 Luminex Corporation Methods for detection and quantification of small RNA
US20110077168A1 (en) * 2008-06-17 2011-03-31 Nitzan Rosenfeld Methods for distinguishing between specific types of lung cancers
CN101475984A (zh) * 2008-12-15 2009-07-08 江苏命码生物科技有限公司 一种非小细胞肺癌检测标记物及其检测方法、相关生物芯片和试剂盒

Similar Documents

Publication Publication Date Title
JP2014509522A5 (enExample)
Rasmussen et al. High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
WO2015095226A3 (en) Preserving genomic connectivity information in fragmented genomic dna samples
Matsuo et al. Artificial enzymes with protein scaffolds: Structural design and modification
WO2015200717A3 (en) Pcr-activated sorting (pas)
JP2015171384A5 (enExample)
JP2017055769A5 (enExample)
JP2016195614A5 (enExample)
EP3029155A3 (en) Method to use gene expression to determine likelihood of clinical outcome of renal cancer
WO2014030066A3 (en) Rolling circle based methods identifying nucleic acids
WO2012099805A3 (en) Nanoparticle based immunological stimulation
WO2013083264A8 (en) Dna polymerases with improved activity
IL259672B2 (en) Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-vegf
WO2015148218A3 (en) Isothermal amplification under low salt condition
WO2013083263A8 (en) Dna polymerases with improved activity
NZ748624A (en) Methods of selecting an individual who will benefit from treatment with a telomerase inhibitor using a formalin fixed paraffin embedded (ffpe) biological sample of solid tumor cancer cells
JP2014533960A5 (enExample)
JP2017537658A5 (enExample)
JP2013516982A5 (enExample)
JP2017516501A5 (enExample)
MY184632A (en) A method of identifying parentage in freshwater prawn macrobrachium rosenbergii
WO2014136124A3 (en) Multiplex real time pcr testing kit for the simultaneous detection of hepatitis virus
WO2016060537A3 (fr) Sondes et amorces pour la quantification rapide et fiable des gènes spécifiques au cancer de la prostate en utilisant des gènes contrôles adéquats
JP2013534810A5 (enExample)
EP2576816A4 (en) METHOD AND KIT FOR THE DISTINCTION BETWEEN BREAST CANCER AND A GOOD BREAST DISEASE